TFF Pharmaceuticals, Inc.
TFFPDelisted Mar 6, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001733413
TFF Pharmaceuticals, Inc. was delisted on Mar 6, 2025; its insiders filed their last Form 4 on Jul 8, 2024; 23 institutions reported holding it in 13F filings for Q3 2024, worth $1.48M in total; no superinvestor held it.
Q3 2023 vs. Q2 2023
How the institutions holding TFF Pharmaceuticals, Inc. changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Q3 2023 | Change |
|---|---|---|---|
| Holders | 33 | 41 | +8 |
| Shares | 6.42M | 11.5M | +5.13M (+79.9%) |
| Value | $3.02M | $4.04M | +$1.03M (+34.0%) |
New holders (9)
Institutions that held TFF Pharmaceuticals, Inc. at the end of Q3 2023 but not at the end of Q2 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Fermata Advisors, LLC | 24,032 | $8.41K | 0.00% |
| XTX Topco Ltd | 21,885 | $7.66K | 0.00% |
| Virtu Financial LLC | 15,764 | $6.00K | 0.00% |
| Susquehanna International Group, LLP | 16,507 | $5.78K | 0.00% |
| Janney Montgomery Scott LLC | 14,350 | $5.00K | 0.00% |
| Nations Financial Group Inc, | 12,500 | $4.38K | 0.00% |
| Venturi Wealth Management, LLC | 8,273 | $2.90K | 0.00% |
| JPMorgan Chase & Co | 61 | $21 | 0.00% |
| Qube Research & Technologies Ltd | 1 | $0 | 0.00% |
Sold out (1)
Institutions that held TFF Pharmaceuticals, Inc. at the end of Q2 2023 and filed for Q3 2023 without it.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Royal Bank of Canada | 137 | $0 |